Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP178803.RA79KpLlQxTIFKSGdtoj05Sga_iIttTdjWYUI-CYo7gw0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP178803.RA79KpLlQxTIFKSGdtoj05Sga_iIttTdjWYUI-CYo7gw0130_assertion type Assertion NP178803.RA79KpLlQxTIFKSGdtoj05Sga_iIttTdjWYUI-CYo7gw0130_head.
- NP178803.RA79KpLlQxTIFKSGdtoj05Sga_iIttTdjWYUI-CYo7gw0130_assertion description "[JAB1 overexpression is involved in the pathogenesis of pancreatic cancer through JAB1-mediated p27 degradation and that control of JAB1 expression is a novel therapeutic target in patients with pancreatic adenocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP178803.RA79KpLlQxTIFKSGdtoj05Sga_iIttTdjWYUI-CYo7gw0130_provenance.
- NP178803.RA79KpLlQxTIFKSGdtoj05Sga_iIttTdjWYUI-CYo7gw0130_assertion evidence source_evidence_literature NP178803.RA79KpLlQxTIFKSGdtoj05Sga_iIttTdjWYUI-CYo7gw0130_provenance.
- NP178803.RA79KpLlQxTIFKSGdtoj05Sga_iIttTdjWYUI-CYo7gw0130_assertion SIO_000772 16951171 NP178803.RA79KpLlQxTIFKSGdtoj05Sga_iIttTdjWYUI-CYo7gw0130_provenance.
- NP178803.RA79KpLlQxTIFKSGdtoj05Sga_iIttTdjWYUI-CYo7gw0130_assertion wasDerivedFrom lhgdn-20090331 NP178803.RA79KpLlQxTIFKSGdtoj05Sga_iIttTdjWYUI-CYo7gw0130_provenance.
- NP178803.RA79KpLlQxTIFKSGdtoj05Sga_iIttTdjWYUI-CYo7gw0130_assertion wasGeneratedBy ECO_0000203 NP178803.RA79KpLlQxTIFKSGdtoj05Sga_iIttTdjWYUI-CYo7gw0130_provenance.